| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000030929 |
| Receipt No. | R000035321 |
| Scientific Title | Non-inferior comparative study comparing One or Two day antimicrobial prophylaxis in clean orthopaedic surgery |
| Date of disclosure of the study information | 2018/04/01 |
| Last modified on | 2022/01/25 (Ver. 13) |
| Basic information | ||
| Public title | Non-inferior comparative study comparing One or Two day antimicrobial prophylaxis in clean orthopaedic surgery
|
|
| Acronym | NOCOTA study
|
|
| Scientific Title | Non-inferior comparative study comparing One or Two day antimicrobial prophylaxis in clean orthopaedic surgery
|
|
| Scientific Title:Acronym | NOCOTA study
|
|
| Region |
|
|
| Condition | ||
| Condition | Clean orthopedic surgeries which required hospitalization | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Compare the effectiveness of preventive antibiotics within 24 hours and within 24-48 hours after clean orthopedic surgery |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Surgical site infections, urinary tract infections, respiratory tract infections, or other infections which required the use of antibiotics within 30 days after orthopedic surgery |
| Key secondary outcomes | other adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Administration of prophylactic antibiotics within 24 hours after surgery | |
| Interventions/Control_2 | Administration of prophylactic antibiotics within 24-48 hours after surgery | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) aged 20 years or older,
2) hospitalized patients, 3) clean surgery, 4) patient with a good command of Japanese, 5) who were able to give consent on their own or through relatives, 6) who had a primary intention wound closure. |
|||
| Key exclusion criteria | 1) operations involving use of external fixations,
2) amputations, 3) needle biopsies, 4) implant removal, 5) reconstructive surgery involving skin tissue such as flap surgery, 6) patients receiving antibiotic therapy prior to surgery, 7) percutaneous vertebroplasty (balloon kyphoplasty, vertebroplasty, etc.) 8) procedures performed in collaboration with other departments. |
|||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kanto Rosai Hospital | ||||||
| Division name | Department of orthopedic surgery | ||||||
| Zip code | 211-8510 | ||||||
| Address | 1-1 Kizukisumiyoshi-cho, Nakahara-ku , Kawasaki City, Kanagawa Prefecture, Japan | ||||||
| TEL | 044-411-3131 | ||||||
| okazarov@kantoh.johas.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | the University of Tokyo Hospital | ||||||
| Division name | Department of Orthopaedic Surgery and Spinal Surgery | ||||||
| Zip code | 112-8655 | ||||||
| Address | 7-3-1Hongo, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| Homepage URL | http://ossi.jp/about/ | ||||||
| knagata-tky@umin.ac.jp | |||||||
| Sponsor | |
| Institute | Society for Orthopaedic Surgical Site Infection |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tokyo Metropolitan Government |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Japan Organization of Occupational Health and Safety Kanto Rosai Hospital |
| Address | 1-1 Kizukisumiyoshi-cho, Nakahara-ku , Kawasaki City, Kanagawa Prefecture, Japan |
| Tel | 044-411-3131 |
| ossijapan@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京都立広尾病院(東京都)
関東労災病院(神奈川県) 東京都立駒込病院(東京都) 東京都立多摩総合病院整形外科(東京都) 東京都健康長寿医療センター(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://ossi.jp/info/ |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | http://ossi.jp/info/ | ||||||
| Number of participants that the trial has enrolled | 1232 | ||||||
| Results | The SSI and HAI rate may be equivalent between Group 24 and Group 48. | ||||||
| Results date posted |
|
||||||
| Results Delayed |
|
||||||
| Results Delay Reason | The statistical analysis will need long time. | ||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | (1) age more than 20 years; (2) hospitalized patients; (3) patients who underwent clean surgery based on CDC wound classification system; (4) patients with a good command of the Japanese language; (5) patients able to give consent on their own or through relatives; and (6) a primary intention wound closure. | ||||||
| Participant flow | In this study, patients will be divided into two groups of different AMP duration using the institution-by-period cluster allocation system. Patients will not be informed of allocation schedule preoperatively. | ||||||
| Adverse events | Adverse events, including anaphylaxis, will not be observed. | ||||||
| Outcome measures | Patients' background and (1) SSI, (2) UTI, (3) RTI, or (4) other infectious diseases. Secondary outcomes will include the prevalence of diseases (1)-(4), (5)mortality, (6) cardiovascular events observed within 30 days after surgery, (7) prolonged hospitalization for >30 days, and (8) the rate of antibiotic resistance of SSI pathogens. | ||||||
| Plan to share IPD | no | ||||||
| IPD sharing Plan description | no | ||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | The patient registration was terminated on December 31, 2018. Data were fixed around June 30, 2019. In order to evaluate the onset of infection within 30 days after surgery. Data analysis was conducted by the end of March 2020.Submission will be performed by August 2020. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035321 |